Source: Eur Respir J , 49 (4)  1601731; DOI: 10.1183/13993003.01731-2016
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Aoife M. Murphy, Amandine Thomas, Sophie J. Crinion, Brian D. Kent, Murtaza M. Tambuwala, Aurelie Fabre, Jean-LouisPepin, Helen M. Roche, Claire Arnaud, Silke Ryan. Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation. Eur Respir J , 49 (4)  1601731; DOI: 10.1183/13993003.01731-2016

Member's Comments

No comment yet.

Related content which might interest you: The inflammation and insulin resistance in obstructive sleep apnea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Metabolic aspects of obstructive sleep apnoea syndrome Source: Eur Respir Rev 2009; 18: 113-124 Year: 2009 Local airway inflammation in obstructive sleep apnoea: the role of leptin Source: Eur Respir J 2006; 28: Suppl. 50, 645s Year: 2006 Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia Source: Eur Respir J 2012; 39: 1492-1500 Year: 2012 Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea Source: Eur Respir J 2011; 37: 89-97 Year: 2011 Adipose tissue in obesity and obstructive sleep apnoea Source: Eur Respir J 2012; 39: 746-767 Year: 2012 Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007 Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Relationship between upper airway inflammation and systemic inflammation in obstructive sleep apnoea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Intermittent hypoxia in sleep apnea: a cause of inflammatory activation Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007 Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003 Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea Source: Eur Respir J 2009; 34: 1390-1398 Year: 2009 Insulin resistance in obstructive sleep apnea patients Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Ghrelin and impaired glucose tolerance in obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 666s Year: 2005 Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009 Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003 Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005 Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea Source: Eur Respir J 2009; 33: 793-796 Year: 2009 Adipose tissue as a key player in obstructive sleep apnoea Source: Eur Respir Rev, 28 (152) 190006; 10.1183/16000617.0006-2019 Year: 2019